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Abstract 
 
The incidence of opioid use disorder (OUD) has grown to epidemic proportions.  Infants 
exposed to opioids inutero are likely to experience withdrawal symptoms during the 
hours and days immediately following birth, known as Neonatal Abstinence Syndrome 
(NAS). Research indicates maximizing non-pharmacologic, supportive management 
decreases Neonatal Intensive Care Unit (NICU) admissions, the length of stay, and the 
severity of NAS. The purpose of this project is to evaluate the effects of an antepartum 
consult designed to prepare mothers with OUD to participate in this nonpharmacologic 
care. The Women and Infants Substance Help (WISH) Center delivers prenatal care for 
women with OUD. Women receiving care at WISH were given an antenatal consult to 
inform them of the proposed plan of care for their infant after delivery. Outcomes were 
compared to mothers from WISH who did not receive the consult, to assess the 
consistency of mothers rooming-in and breastfeeding to treat NAS in the first 5-7 days, 
as measured by whether the mother roomed-in with her baby, the percentage of babies 
who received their mother’s milk, and the length of hospital stay for the baby. While 
there was a small improvement in these measures among the mothers who received 
the consult, it did not reach statistical significance.  A secondary analysis supported 
existing studies which associated rooming-in and breastfeeding with shorter lengths of 
stay for infants.  The overall success of this model of care warrants continuation.  
Further investigation is needed to identify and refine the factors which contribute to this 
success. 
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Introduction 
 
The incidence of opioid use disorder (OUD) in the United States had grown to 
epidemic proportions.  In 2014 the number of individuals who were nonmedical users of 
pain relievers was estimated at 4.3 million, with an additional 435,000 using heroin 
(Center for Behavioral Health Statistics and Quality, 2015). Women of childbearing age 
are no exception. The prevalence of OUD in pregnant women increased by 127% from 
1998 to 2011 (Maeda, Bateman, Clancy, Creanga, & Leffert, 2014).  Infants born to 
women with OUD are likely to experience withdrawal symptoms during the hours and 
days immediately following birth.  This withdrawal is known as Neonatal Abstinence 
Syndrome (NAS). 
The incidence of NAS per 1000 births/year between 2000 and 2012 increased 
from 1.2 to 5.8.  In 2012 the mean length of hospital stay for unaffected newborns was 
1.2 days with an associated cost per admission of $3,500.  For babies with NAS this 
increased to 16.9 days and $66,700 (Patrick, Davis, Lehman & Cooper, 2015).  A review 
of national trends in Neonatal Intensive Care Units (NICU) revealed the frequency of 
admissions for infants with NAS increased from 7 per 1000 in 2004 to 27 per 1000 in 
2013.  Over the same period, the average length of hospital stays for these infants 
increased from 13 to 19 days (Tolia et al., 2015). 
Guidelines for the use of pharmacologic management of NAS symptoms are not 
consistent, but almost always result in the baby being admitted to the NICU.  Once 
pharmacologic management is initiated, the baby receives multiple doses, which are 
slowly weaned.  This scenario results in significant exposure to pharmacotherapy and 
separation of the mother and infant during a critical bonding time. 
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Current research indicates maximizing non-pharmacologic, supportive 
management decreases NICU admissions, the length of stay, and the severity of NAS 
(Grossman et al, 2017). The purpose of this project is to evaluate the effects of an 
antepartum consult designed to prepare OUD mothers to participate in the 
nonpharmacologic care of their newborns. In neonates experiencing NAS, how does a 
maternal preparation/education/ support intervention, compared to current procedures 
affect the consistency of mothers rooming-in and breastfeeding to treat NAS in the first 
5-7 days, as measured by whether the mother rooms-in with her baby, the percentage 
of babies who receive their mother’s milk, and the length of hospital stay for the baby? 
Literature Review 
The literature review was guided by a search of CINHAL, PubMed, Medline, and 
Google Scholar. The key term used was Neonatal Abstinence Syndrome.  Then a 
variety of terms were added, including treatment, quality improvement, breastfeeding, 
and rooming-in, as well as opioid addiction, prenatal education or preparation, and 
pregnancy.  Included in the search were primary research and review articles, 
professional and clinical guidelines, and quality improvement projects.  Further 
investigation followed references from associated literature. Where possible, research 
and review articles were limited to those published since 2012.   
Medication Assisted Treatment for pregnant women with OUD is the safest course 
of action but results in babies experiencing NAS (Hudak & Tan, 2012). These babies are 
at higher risk for long-term complications, but the quality of their parental relationships 
and home life can favorably affect outcomes (Baldacchino, Arbuckle, Petrie, & 
McCowan, 2015; Nygaard, Slinning, Moe & Walhovd, 2017; Oei et al., 201 Ornoy, 
2003).  Treatment for NAS is inconsistent and often leads to NICU admissions which 
separates mothers and babies at a critical bonding time (Bagley, Wachman, Holland & 
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Brogly, 2014).  Women with OUD already face many unique environmental stressors, 
and this places them in an unwelcoming environment (Gopman, 2014; Atwood et al., 
2016; Cleveland & Bonugli, 2014). 
These combinations of factors have led healthcare providers to seek more 
compassionate, consistent, and evidence-based approaches to the treatment of NAS, 
which also have the potential for improving short and long-term outcomes.  Two family-
centered interventions for NAS that emphasize the mother-infant relationship are 
breastfeeding and rooming-in.  These are simple, non-pharmacologic measures that 
place the mother at the center of the care of her baby and may improve outcomes for 
the mothers and infants (Edwards & Brown, 2016; Mcqueen & Murphy-Oikonen, 2016).  
The management of infants at risk for NAS that includes standardization of 
protocols, an emphasis on non-pharmacologic interventions, and the use of alternative 
treatment approaches is associated with better infant outcomes (Grossman, Seashore, 
& Holmes, 2017).  Implementing programs for NAS which emphasize parental 
presence, rooming-in with close contact between women with OUD and their newborns 
and avoiding NICU admissions demonstrated significant decreases in the percentage of 
infants requiring treatment with morphine, in the length of stay for these babies, and in 
the cost of treatment (Boucher, 2017; Howard et al., 2017; Holmes et al., 2016; 
Newman et al., 2015).    
Breastfeeding is both safe and recommended in the context of OUD, provided the 
mother has demonstrated sufficient sobriety (Reece-Stremtan, Marinelli, & Academy of 
Breastfeeding Medicine, 2015).  The amount of both methadone and buprenorphine that 
is present in mother’s milk is clinically insignificant, regardless of the maternal dose 
(Hale & Rowe, 2016).  Breastfeeding for the management of NAS has been shown to 
reduce the duration and severity of NAS symptoms, was associated with a decrease in 
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the need for pharmacologic treatment for NAS while promoting infant attachment and 
bonding, and shortened the length of stay compared to infants who were formula fed 
(Pritham, 2013; Short, Gannon & Abatemarco, 2016).  
The value of rooming-in and breastfeeding for the treatment of babies with NAS is 
clearly demonstrated.  These interventions improve immediate outcomes for babies, but 
also set the stage for improving longer-term outcomes by enhancing the relationship 
and strengthening the bond between parents and their babies.  However, parents need 
to be informed in advance of the significant role they are expected to play during the 
first 5-7 days after birth, requiring a longer stay in the hospital.  Without the active 
participation of the parents, neither of these interventions can be employed. 
Published literature regarding evidence-based strategies to prepare, motivate, and 
engage parents with OUD in this process is sparse.  While several authors refer to 
parental preparation in the overall treatment plan for babies with NAS (Grossman et al., 
2017; Mcqueen & Murphy-Oikonen, 2016; McKeever, Spaeth-Brayton & Sheerin, 2014; 
Pritham, 2013; Sutter, Gopman & Leeman, 2017) only three studies where found that 
focused on the effects of a specific, prenatal education intervention involving women 
with OUD. 
Newman et al. (2015) implemented an intervention which included antenatal 
education about the symptoms of NAS and nonpharmacologic strategies, along with 
training hospital staff to consistently assess NAS symptoms.  This led to a successful 
transition to routine rooming-in for mothers with OUD and their babies and decreased 
the number of babies requiring pharmacotherapy and average length of stay.  Crook 
and Brandon (2017) offered a series of three, prenatal breastfeeding classes to OUD 
women and measured the impact on subsequent breastfeeding rates and length of stay 
for infants with NAS.  They found a statistically significant decrease in the length of stay, 
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but no significant increase in the breastfeeding rate. Finally, Giles, Ren, and Founds 
(2016) tested a prenatal educational intervention for OUD women, designed to increase 
knowledge regarding NAS and early parenting skills.  They found no statistically 
significance difference in the women’s knowledge scores pre-and post-intervention but 
did receive affirmation that the women perceived themselves more effectively prepared 
for the postpartum period after receiving the education. 
A Protective Factors Framework informs this project.  An educational intervention 
contributed to strengthening families by emphasizing the value of the parental presence, 
providing guidance and support, and teaching the parents appropriate strategies for 
caring for their infant.  This helps build protective factors such as parental resilience, 
social connections, and knowledge of parenting and child development.  According to 
the Protective Factors Framework, improving these protective factors result in 
strengthened families, optimal child development, and reduced likelihood of child abuse 
and neglect (The Center for the Study of Social Policy, 2017). 
Method 
The project’s overall approach was program evaluation, in which a group of 
women receiving standard care were compared to a group who received an additional 
consult. The Women and Infants Substance Help (WISH) Center is located on the 
campus of SSM Health St. Mary’s Hospital, and delivers prenatal care for women with 
OUD.  Beginning January 22, 2018, women receiving prenatal care at WISH were given 
an antenatal consult designed to inform them of the proposed plan of care for 
their infant after delivery.  The consult covered the topics as described in Appendix A 
(Antepartum Consult Topics) and was documented in the patient’s chart.  
The postpartum care setting was St. Mary’s Hospital in St. Louis.  Mothers and 
babies are cared for as a couplet and this unit sees an average of 14-20 opioid 
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dependent mothers and their newborns per month.  A pilot project, modeled after the 
work of Grossman and colleagues from Yale New Haven Children’s Hospital (Grossman 
et al., 2017) was initiated on November 6, 2017.  A new method of assessing NAS 
symptoms was implemented, transitioning from the modified Finnegan Scoring System 
to the Eat/Sleep/Console assessment, all mothers were offered and encouraged to 
remain rooming-in with their baby after their own discharge, and pharmacologic 
treatment, when necessary, was given on a PRN basis and did not require an 
immediate transfer to NICU.   
The sample from whom the data was collected included babies who were being 
observed for NAS at St. Mary’s Hospital newborn nursery, and their mothers, during the 
period between November 6, 2017 and April 24, 2018.  This provided for a comparison 
of approximately three months of data from women who delivered before the antenatal 
consults were initiated (November 6, 2017 to January 21, 2018), and three months of 
data for those who delivered after having the consult (January 22, 2018 to April 24, 
2018).  Only couplets in which the mothers received prenatal care at the WISH Center 
were included.  Of this group, subjects were excluded if they did not receive the 
antenatal consult after it was initiated (January 22, 2018), or if the baby was admitted to 
NICU for medical reasons not related to the symptoms of NAS.   
Administrative approval from both settings were provided by the Medical Director 
of the WISH Center, and the Director of Women’s Services at St. Mary’s Hospital. 
Human subject approval to conduct the project was granted from the Institutional 
Review Board (IRB) at the University of Missouri – St. Louis and the IRB at St. Mary’s 
Hospital.  
Results 
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Data was collected from 23 couplets before the consult was initiated, and 17 
couplets in which the mother received the consult. (See Appendix B: Data Collection 
Sheet).  Sample description and demographics from each group is displayed in Table 1. 
An Independent samples t-test was conducted to examine whether a significant 
difference existed between the mean length of stay for infants in the pre- and post-
intervention groups. There was no significant difference found. A Chi-square analyses 
was performed to detect whether there was a relationship between receiving the consult 
and babies receiving their mom’s milk.  Due to the small sample size, a Fisher’s Exact 
test was used to analyze the relationship between the consult and rooming-in.  Neither 
of these relationships was found to be statistically significant.  Fisher’s exact tests were 
also performed and found no statically significant relationships between the consult and 
the baby receiving morphine or being admitted to NICU (Table 2).   
A secondary analysis was performed to detect whether any of the variables were 
more frequently associated with another, by conducting Pearson correlation analyses. 
There was a significant positive correlation between rooming-in and infant’s length of 
stay in days (rp = 0.44, p = .005). The correlation coefficient between these two 
variables was 0.44 indicating a moderate effect size. This result indicates that as mom 
rooms-in less, the length of stay tends to increase. 
A similar trend existed between mother’s milk and length of stay. There was a 
significant positive correlation between receiving mom’s milk and infant’s length of stay 
(rp = 0.39, p = .014). The correlation coefficient between these variables was 0.39 
indicating a moderate effect size. This indicates that as the incidence of baby getting 
mom’s milk decreases, the length of stay tends to increase.  
And finally, there was a significant positive correlation between rooming-in and 
receiving mom’s milk (rp = 0.41, p = .008). The correlation coefficient between rooming-
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in and receiving mom’s milk was 0.41 indicating a moderate effect size. This indicates 
that as moms room in more, the incidence of baby receiving mom’s milk tends to 
increase. 
Discussion 
While there was a clinical improvement in the key measures among the mothers 
who received the consult, the increase did not reach statistical significance.  Due to the 
small sample size, it was not possible to effectively analyze the impact of the 
intervention.  Another confounding factor was the hospital’s concurrent implementation 
of a new model of care emphasizing rooming-in and non-pharmacologic treatment for 
babies being observed for NAS.  While all couplets in this project were cared for using 
this model, it’s application was being refined throughout this period.  It is unknown what 
effect this had on the outcomes.  The effects of these factors would be diminished with 
a larger sample size and a longer period of data collection. 
  Only couplets in which the mothers received prenatal care at the WISH Center 
were included in this project.  While this provided a consistent prenatal experience, 
participants at the WISH Center routinely receive more specialized education at each 
visit.  Repeating this project with mothers receiving prenatal care in non-specialized 
settings may produce different results. 
The secondary analyses supported existing studies which associated rooming-in 
and breastfeeding with shorter lengths of stay for infants.  The finding that rooming-in is 
associated with receiving mom’s milk logically follows that breastfeeding and the 
availability of mother’s milk could be compromised if a mother is not rooming-in. 
While the results of this consult did not reach statistical significance, the clinical 
significance of this model of care should not be overlooked.  There still exists great 
variability in the assessment and management of NAS.  The average length of stay for 
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babies treated for NAS is being reported as at least 16 to 25 days (Pritham, 2013; 
Howard et al., 2017; Newman et al., 2015). After a rooming-in intervention, Newman 
and colleagues reported decreasing the length of stay to 8 days (Newman et al., 2015).  
Grossman and colleagues brought the average length of stay down to 5.9 days after 
applying a new method of assessment and focusing on nonpharmacologic care 
(Grossman et al., 2017).  The practice in the hospital setting for this project is modeled 
after the latter, and achieved similar results.  The pre-consult average length of stay 
was  6.17 days and the post-consult group was 5.65. 
Future study should focus on the refinement of practices which support 
mother/family-centered, non-pharmacologic measures to treat infants at risk for NAS.  In 
addition, research is needed to follow more long-term outcomes for these families. This 
would include associating the delivery of family-centered, nonpharmacologic care with 
the outcomes of child development and behavior, breastfeeding rates and duration, 
quality of mother-infant bonding, and family stability. 
Conclusion 
An antenatal consult designed to educate, motivate, and empower mothers with 
OUD to participate in the care of their newborns was delivered to women receiving 
prenatal care at a specialty clinic.  A comparison was made between mothers from this 
clinic who received the consult and those who did not.  While there was a clinical 
improvement in the number of babies who received their mom’s milk, in the level of 
rooming-in, avoiding morphine treatment and NICU admissions, the relationship did not 
reach statistical significance.  Likewise, although there was a slight decrease in the 
length of stay for the group whose mothers received the consult, the difference was not 
statistically significant.  A secondary analysis supported existing studies which correlate 
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rooming-in and breastfeeding with shorter lengths of stays for infants, and correlated 
rooming-in with breastfeeding. 
The overall success of the model of care implemented with this population during 
the study period warrants continuation.  Further investigation is needed to identify and 
refine the factors which contribute to this success. 
 
 
References 
 
Atwood, E. C., Sollender, G., Hsu, E., Arsnow, C., Flanagan, V., Celenza, J., ... & 
Holmes, A. V. (2016). A qualitative study of family experience with hospitalization 
for neonatal abstinence syndrome. Hospital pediatrics, hpeds-2016. 
Bagley, S. M., Wachman, E. M., Holland, E., & Brogly, S. B. (2014). Review of the 
assessment and management of neonatal abstinence syndrome. Addiction 
science & clinical practice, 9(1), 19. 
Baldacchino, A., Arbuckle, K., Petrie, D. J., & McCowan, C. (2015). Erratum: 
Neurobehavioral consequences of chronic intrauterine opioid exposure in infants 
and preschool children: a systematic review and meta-analysis. BMC 
psychiatry, 15(1), 134. 
Boucher, A. M. (2017). Nonopioid Management of Neonatal Abstinence 
Syndrome. Advances in Neonatal Care, 17(2), 84-90. 
Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in 
the United States: Results from the 2014 National Survey on Drug Use and 
Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved 
from http://www.samhsa.gov/ data/ 
INVOLVE OUD WOMEN WITH THEIR INFANTS 13 
 
Cleveland, L. M., & Bonugli, R. (2014). Experiences of mothers of infants with neonatal 
abstinence syndrome in the neonatal intensive care unit. Journal of Obstetric, 
Gynecologic, & Neonatal Nursing, 43(3), 318-329. 
Crook, K., & Brandon, D. (2017). Prenatal breastfeeding education: Impact on infants 
with Neonatal Abstinence Syndrome. Advances in Neonatal Care, 17(4), 299-
305. 
Edwards, L., & Brown, L. F. (2016). Nonpharmacologic management of neonatal 
abstinence syndrome: an integrative review. Neonatal Network, 35(5), 305-313. 
Giles, A. C., Ren, D., & Founds, S. (2016). Development, implementation, and 
evaluation of a pilot parenting educational intervention in a pregnancy 
buprenorphine clinic. Nursing for women's health, 20(3), 258-267. 
Gopman, S. (2014). Prenatal and postpartum care of women with substance use 
disorders. Obstetrics and Gynecology Clinics, 41(2), 213-228. 
Grossman, M. R., Berkwitt, A. K., Osborn, R. R., Xu, Y., Esserman, D. A., Shapiro, E. 
D., & Bizzarro, M. J. (2017). An Initiative to Improve the Quality of Care of Infants 
with Neonatal Abstinence Syndrome. Pediatrics, 139(6), e20163360. 
Grossman, M., Seashore, C., & Holmes, A. V. (2017). Neonatal Abstinence Syndrome 
Management: A Review of Recent Evidence. Reviews on recent clinical trials. 
Hale, T. W., & Rowe, H. E. (2016). Medications and Mothers’ Milk 2017. New York, NY: 
Springer Publishing Company. 
Holmes, A. V., Atwood, E. C., Whalen, B., Beliveau, J., Jarvis, J. D., Matulis, J. C., & 
Ralston, S. L. (2016). Rooming-in to treat neonatal abstinence syndrome: 
improved family-centered care at lower cost. Pediatrics, 137(6), e20152929. 
INVOLVE OUD WOMEN WITH THEIR INFANTS 14 
 
Howard, M. B., Schiff, D. M., Penwill, N., Si, W., Rai, A., Wolfgang, T., ... & Wachman, 
E. M. (2017). Impact of Parental Presence at Infants’ Bedside on Neonatal 
Abstinence Syndrome. Hospital Pediatrics, 7(2), 63-69. 
Hudak, M. L., & Tan, R. C. (2012). Neonatal drug withdrawal. Pediatrics, 129(2), e540-
e560. 
Maeda, A., Bateman, B. T., Clancy, C. R., Creanga, A. A., & Leffert, L. R. (2014). Opioid  
abuse and dependence during pregnancy temporal trends and obstetrical 
outcomes. Anesthesiology: The Journal of the American Society of 
Anesthesiologists, 121(6), 1158-1165. Retrieved from 
https://www.ncbi.nlm.nih.gov/pubmed/25405293 
McKeever, A. E., Spaeth-Brayton, S., & Sheerin, S. (2014). The role of nurses in 
comprehensive care management of pregnant women with drug 
addiction. Nursing for women's health, 18(4), 284-293. 
Mcqueen, K., & Murphy-Oikonen, J. (2016). Neonatal Abstinence Syndrome. New 
England Journal of Medicine,375(25), 2468-2479. doi:10.1056/nejmra1600879 
Newman, A., Davies, G. A., Dow, K., Holmes, B., Macdonald, J., McKnight, S., & 
Newton, L. (2015). Rooming-in care for infants of opioid-dependent 
mothers. Canadian Family Physician, 61(12), e555-e561. 
Nygaard, E., Slinning, K., Moe, V., & Walhovd, K. B. (2017). Cognitive function of 
youths born to mothers with opioid and poly-substance abuse problems during 
pregnancy. Child Neuropsychology, 23(2), 159-187. 
Oei, J. L., Melhuish, E., Uebel, H., Azzam, N., Breen, C., Burns, L., ... & Feller, J. M. 
(2017). Neonatal abstinence syndrome and high school performance.    
Pediatrics, 139(2), e20162651. 
INVOLVE OUD WOMEN WITH THEIR INFANTS 15 
 
Ornoy, A. (2003). The impact of intrauterine exposure versus postnatal environment in 
neurodevelopmental toxicity: long-term neurobehavioral studies in children at risk 
for developmental disorders. Toxicology Letters,140-141, 171-181. 
doi:10.1016/s0378-4274(02)00505-2 
Patrick, S. W., Davis, M. M., Lehman, C. U., & Cooper, W. O. (2015). Increasing 
incidence and geographic distribution of neonatal abstinence syndrome: United 
States 2009-2012. Journal of perinatology: official journal of the California 
Perinatal Association, 35(8), 650. 
Pritham, U. A. (2013). Breastfeeding Promotion for Management of Neonatal 
Abstinence Syndrome. Journal of Obstetric, Gynecologic & Neonatal 
Nursing,42(5), 517-526. doi:10.1111/1552-6909.12242 
Reece-Stremtan, S., Marinelli, K. A., & Academy of Breastfeeding Medicine. (2015). 
ABM clinical protocol# 21: guidelines for breastfeeding and substance use or 
substance use disorder, revised 2015. Breastfeeding Medicine, 10(3), 135-141. 
Short, V. L., Gannon, M., & Abatemarco, D. J. (2016). The Association Between 
Breastfeeding and Length of Hospital Stay Among Infants Diagnosed with 
Neonatal Abstinence Syndrome: A Population-Based Study of In-Hospital 
Births. Breastfeeding Medicine,11(7), 343-349. doi:10.1089/bfm.2016.0084 
Sutter, M. B., Gopman, S., & Leeman, L. (2017). Patient-centered Care to Address 
Barriers for Pregnant Women with Opioid Dependence. Obstetrics and 
Gynecology Clinics, 44(1), 95-107. 
The Center for the Study of Social Policy. (2017). Strengthening Families: A Protective 
Factors Framework. Retrieved from https://www.cssp.org/young-children-their-
families/strengtheningfamilies/about#state-strengthening-families-partners 
INVOLVE OUD WOMEN WITH THEIR INFANTS 16 
 
Tolia, V. N., Patrick, S. W., Bennett, M. M., Murthy, K., Sousa, J., Smith, P. B., ... & 
Spitzer, A. R. (2015). Increasing incidence of the neonatal abstinence syndrome 
in US neonatal ICUs. New England Journal of Medicine, 372(22), 2118-2126. 
Table 1 
Participants’ Description and Demographics 
 
Pre-intervention 
Group 
Post-intervention 
Group 
Total Subjects 
Race/Ethnicity 
   
     Caucasian 13 (57%) 15 (88%) 28 (70%) 
     African American  6 (26%)  2 (12%)  8 (20%) 
     Other  4 (17%)  0 (0%)  4 (10%) 
Average Age/years 30.375 29.22 30.08 
Receiving MAT 
   
     Yes, Buprenorphine 13 (57%) 10 (59%) 23 (57.5%) 
     Yes, Methadone  9 (39%)  7 (41%) 16 (40%) 
     No  1 (4%)  0 (0%)  1 (2.5%) 
Eligible to Provide Milk 
   
     Yes 12 (52%) 12 (71%) 24 (60%) 
     No 11 (48%)  5 (29%) 16 (40%) 
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Table 2 
Results from Statistical Analyses of variables compared to receiving/not receiving 
consult 
                          Pre-intervention    Post-intervention 
                                  Group                  Group 
Variable M SD M SD t p d 
Length of 
Stay 
6.17 2.46 5.65 1.00 0.93 .360 0.28 
Note. Degrees of Freedom for the t-statistic = 38. d represents Cohen's d. 
 
Variable Chi-square 
Coefficient 
Fisher’s 
Exact 
Test Statistic 
Receiving 
Mom’s Milk 
0.6282*  
Rooming-in 
 
1.0* 
Receiving 
Morphine 
 0.1229* 
NICU 
Admission 
 0.4987* 
*Not significant at P<0.05 
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Appendix A 
 
Antepartum Consult Topics 
 
 
What is mom’s role:    
      You are the treatment  
                Plan to stay until baby is discharged 
                Discuss individual barriers/solutions 
     Importance of breastfeeding if allowed 
 
What to expect after delivery: 
                Symptoms of NAS 
                Hospital protocol for assessing baby 
                Treatment without medicine 
      Treatment with medicine 
 
What can I do: 
       Rooming-in 
       Breastfeeding or pumping milk 
       Keep lights, noise, visitors to a minimum 
       Feed and comfort baby on demand 
       Figure out what works best for your baby 
 
Follow-up after going home: 
                Choose baby’s pediatrician and make first appointment 
                Schedule for continuing appointments 
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Appendix B 
Data Collection Sheet 
Subject #_______ 
Mother age in years________ 
Gestational age at the time of the consult __________ 
Race/Ethnicity:  
1 = Caucasian, non-Hispanic 
2 = African American 
3 = Hispanic 
4 = Other 
MAT: 
1 = Yes, buprenorphine 
2 = Yes, methadone 
3 = no 
Milk OK: 
1 = Mother was eligible to provide milk for baby. 
2 = Mother was not eligible to provide milk for baby. 
Infant Gender: 
1 = Girl 
2 = Boy  
GA_______  
Birth Weight________________  
Discharge Weight______________ 
Room-in: 
1 = Mother/family roomed-in until baby’s discharge. 
2 = Mother/family gave up room before baby’s discharge. 
Number of hours spent in the nursery _________ 
Ever milk: 
1 = yes, received any mom’s milk. 
2 = no, did not receive any mom’s milk. 
Milk at dc: 
1 = yes, Baby was still receiving mom’s milk at discharge. 
2 = no, Baby was not receiving mom’s milk at discharge. 
Baby’s length of stay in days ________ 
Did the baby receive any doses of morphine?  
1 = Yes 
2 = No    
 If so, how many? _______ 
Was the baby admitted to NICU for NAS related issues? 
1 = Yes 
2 = No 
 
